Multiple sclerosis:: Pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-β
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 108 (1-2) , 236-243
- https://doi.org/10.1016/s0165-5728(00)00281-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosisJournal of Neuroimmunology, 1999
- Measurement of serum cytokinesThe Lancet, 1998
- Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overviewJournal of Neuroimmunology, 1997
- Ifn-β 1B Treatment of Relapsingmultiple Sclerosis Has no Effect on Cd3-Induced Inflammatory or Counterregulatory Anti-Inflammatory Cytokine Secretion Ex Vivo After Nine MonthsInternational Journal of Neuroscience, 1997
- The effect of interferon β-1b on lymphocyte-endothelial cell adhesionJournal of Neuroimmunology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesTrends in Biotechnology, 1992
- Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cellsJournal of Immunological Methods, 1988
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosisPublished by Elsevier